AVAiL Study Shows Longest Survival in Patients With Advanced Non-Small Cell Lung Cancer

15.09.2008 15:40:18
Roche Pharmaceuticals: Basel, Switzerland (ots/PRNewswire) - - Final Analysis of Study Confirms Benefit of Avastin(R) for Patients With Lung Cancer BASEL, Switzerland, September 15 /PRNewswire/ -- The final analysis of the Avastin in lung ...

Lesen Sie hier weiter... | Drucken | PDF

Erbitux Significantly Prolongs Survival in 1st-Line Treatment of Non-Small Cell Lung Cancer
Avastin(R) Gives an Additional 4 Months of Life to Patients With one of the Most Common Types of Lung Cancer
Tarceva(R) Delivers Benefits Across Broad Range of NSCLC Patients - Confirmed by New Data
New Report Shows That Despite Poor Survival Rates Lung Cancer is not Prioritized in Europe
/K I L L K I L L K I L L -- Merck Serono/
Data Suggests Promising Overall Survival and Progression-Free Survival With VARGATEF(TM) (BIBF 1120)
Avastin(R) Continues to Demonstrate Long Term Survival for Patients With Metastatic Colorectal Cancer
Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer
New Study Shows That Pegasys Regimen Provides Higher Cure Rates for Hepatitis C Patients
Die globale Lungenkrebskoalition gibt 3. jährlichen Lung Cancer Journalism Awards-Wettbewerb bekannt.

Die globale Lungenkrebskoalition gibt 3. jährlichen Lung Cancer ...

AVAiL Study Shows Longest Survival in Patients With Advanced Non-Small Cell Lung Prolongs Survival in 1st-Line Treatment of Non-Small Cell Lung Cancer

Studenten.de: AVAiL Study Shows Longest Survival in Patients With ...

AVAiL Study Shows Longest Survival in Patients With Advanced Non-Small Cell Lung Avastin in lung study (AVAiL) in patients with advanced lung cancer has shown